<DOC>
	<DOCNO>NCT02043847</DOCNO>
	<brief_summary>In phase I trial , patient relapse refractory multiple myeloma receive standard high dose melphalan autologous stem cell rescue . In addition pre-transplant conditioning include target total marrow irradiation ( TMI ) . This conventional 3+3 phase I trial increase dose TMI maximum tolerate dose ( MTD ) reach . Initial patient enrol receive low possible dose 3Gy . Maximum dose 9Gy .</brief_summary>
	<brief_title>Total Marrow Irradiation With High Dose Melphalan Prior Autologous Transplant Relapsed Refractory Multiple Myeloma ( BMT-03 )</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>1 . Patients meet criterion symptomatic myeloma 2 . Patients progressive myeloma follow initial induction ( patient may receive number treatment regimens include prior autologous transplant ) 3 . Patient age 1875 year time enrollment 4 . Karnofsky performance status â‰¥70 5 . Cardiac function : LVEF &gt; 40 % 6 . Hepatic : Bilirubin &lt; 2x upper limit normal ALT AST &lt; 2.5x upper limit normal 7 . Renal : Creatinine clearance &gt; 30mL/min , estimate calculate 8 . Pulmonary : DLCO , FEV1 , FVC &gt; 50 % predict ( correction hemoglobin ) 1 . Patients diagnosis plasma cell leukemia 2 . Patients truly non secretory myeloma ( patient light chain disease eligible ) 3 . Pregnant breastfeed 4 . Uncontrolled viral , fungal bacterial infection Note : Infection permit evidence response medication . Eligibility HIV infect patient determined casebycase basis . 5 . Patients undergone prior allogeneic stem cell transplant 6 . Prior solid organ transplant 7 . Patients receive prior radiation 20 % bone marrow contain area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Relapsed</keyword>
	<keyword>Refractory</keyword>
	<keyword>Progressive Disease</keyword>
	<keyword>Symptomatic</keyword>
</DOC>